The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infection: Towards personalised medicine

Risultati finali

Website with name, logo, project description, and partner information available, plus posting of recent advances and upcoming events online.

Clinical case reports from all affiliated centers treating Long-COVID patients

Provide clinical evidence and specification of patient cohort disease criteria.

Pubblicazioni

International Journal of Molecular Sciences

Autori: Arora et al.
Pubblicato in: International Journal of Molecular Sciences, 2023, ISSN 1422-0067
Editore: Basel MDPI Center 2000-
DOI: 10.3390/ijms232214057

From rare disorders of immunity to common determinants of infection: Following the mechanistic thread

Autori: Casanova & Abel
Pubblicato in: Cell, 2022, ISSN 1097-4172
Editore: Cell
DOI: 10.1016/j.cell.2022.07.004

Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia

Autori: Zhang et al.
Pubblicato in: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editore: Rockefeller University Press
DOI: 10.1084/jem.20220131

Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage

Autori: Arora et al.
Pubblicato in: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Editore: The Lancet
DOI: 10.1016/S1473-3099(22)00831-3

Human inherited complete STAT2 deficiency underlies inflammatory viral diseases

Autori: Bucciol et al.
Pubblicato in: Journal of Clinical Investigation, 2023, ISSN 1558-8238
Editore: American Society for Clinical Investigation
DOI: 10.1172/JCI168321

Lung cell entry, cell-cell fusion capacity, and neutralisation sensitivity of omicron sublineage BA.2.75

Autori: Arora et al.
Pubblicato in: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Editore: The Lancet
DOI: 10.1016/S1473-3099(22)00591-6

Pharmaceuticals

Autori: Centofanti et al.
Pubblicato in: Pharmaceuticals (Basel), 2024, ISSN 1424-8247
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ph16020240

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

Autori: Lee et al.
Pubblicato in: Science, 2022, ISSN 1095-9203
Editore: Science
DOI: 10.1126/science.abo3627

Autoantibodies against type I IFNs in patients with critical influenza pneumonia

Autori: Zhang et al.
Pubblicato in: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editore: Rockefeller University Press
DOI: 10.1084/jem.20220514

Pathogens

Autori: Skouboe et al.
Pubblicato in: Pathogens, 2022, ISSN 2076-0817
Editore: Basel MDPI AG 2012-
DOI: 10.3390/pathogens12020310

Polyvalent Nano-Lectin Potently Neutralizes SARS-CoV-2 by Targeting Glycans on the Viral Spike Protein

Autori: Budhadev et al.
Pubblicato in: JACS Au, 2023, ISSN 2691-3704
Editore: Washington, DC American Chemical Society [2021]-
DOI: 10.1021/jacsau.3c00163

Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity

Autori: Tangye et al.
Pubblicato in: Journal of Allergy and Clinical Immunology, 2022, ISSN 2772-8293
Editore: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2022.11.010

Nature Communications

Autori: Hoffmann et al.
Pubblicato in: Nature Communications, 2023, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-023-39147-4

Antibody diversity in IVIG: Therapeutic opportunities for novel immunotherapeutic drugs

Autori: von Gunten et al.
Pubblicato in: Frontiers in Immunology, 2023, ISSN 2832-4404
Editore: Lausanne Frontiers Media S.A. 2010-
DOI: 10.48350/181810

Omicron sublineage BQ.1.1 resistance to monoclonal antibodies

Autori: Arora et al.
Pubblicato in: The Lancet Infectious Diseases, 2022, ISSN 1474-4457
Editore: The Lancet
DOI: 10.1016/S1473-3099(22)00733-2

The genetic and evolutionary determinants of COVID-19 susceptibility

Autori: Kerner et al.
Pubblicato in: European Journal of Human Genetics, 2022, ISSN 1476-5438
Editore: Nature
DOI: 10.1038/s41431-022-01141-7

COVID-19: S-Peptide RBD 484–508 Induces IFN-γ T-Cell Response in Naïve-to-Infection and Unvaccinated Subjects with Close Contact with SARS-CoV-2-Positive Patients

Autori: Murdocca et al.
Pubblicato in: Viruses, 2023, ISSN 1999-4915
Editore: Basel MDPI 2009-
DOI: 10.3390/v15071417

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

Autori: Mathian et al.
Pubblicato in: Annals of the Rheumatic Diseases, 2022, ISSN 1468-2060
Editore: BMJ Group on behalf of the European League Against Rheumatism
DOI: 10.1136/ard-2022-222549

Viruses

Autori: Campos-Gonzalez et al.
Pubblicato in: Viruses, 2024, ISSN 1999-4915
Editore: Basel MDPI 2009-
DOI: 10.3390/v15030789

Neutralisation sensitivity of SARS-CoV-2 lineages EG.5.1 and XBB.2.3

Autori: Zhang et al.
Pubblicato in: The Lancet Infectious Diseases, 2023, ISSN 1474-4457
Editore: Elsevier
DOI: 10.1016/S1473-3099(23)00547-9

Inherited and acquired errors of type I interferon immunity govern susceptibility to COVID-19 and multisystem inflammatory syndrome in children

Autori: Bucciol et al.
Pubblicato in: Journal of Allergy and Clinical Immunology, 2023, ISSN 2772-8293
Editore: New York Elsevier, Inc.
DOI: 10.1016/j.jaci.2023.02.003

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

Autori: Sokal et al.
Pubblicato in: Journal of Experimental Medicine, 2022, ISSN 1540-9538
Editore: Rockefeller University Press
DOI: 10.1084/jem.20220258

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica